• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. POD; HCG, KRD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. POD; HCG, KRD Back to Search Results
Catalog Number RBYPOD6
Medical Device Problem Codes Physical Resistance/Sticking (4012); Premature Separation (4045)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/16/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
This device is available for return.A follow up mdr will be submitted upon completion of the device investigation.
 
Event or Problem Description
The patient was undergoing a coil embolization procedure in the lumbar artery using pod coils and a lantern delivery microcatheter (lantern).It should be noted that the patient''s anatomy was tortuous and calcified.During the procedure, the physician encountered resistance while advancing the first pod coil through the middle of the lantern and the coil became stuck.While attempting to remove the pod coil, it unintentionally detached.Therefore, the lantern containing the detached pod coil was removed from the patient and the coil was flushed out on the back table.The procedure was completed using another pod coil, three other coils, and the same lantern.There was no report of an adverse effect to the patient.
 
Additional Manufacturer Narrative
Evaluation of the returned pod coil confirmed that the embolization coil was detached from the pusher assembly.Evaluation revealed that the pet lock was wrinkled and slipped off the proximal end of the pusher assembly.If the pod coil is manipulated at the pet lock against resistance during use, the pet lock may become wrinkled and slip off the pusher assembly.This damage likely contributed to the embolization coil detachment during the procedure.The root cause of the resistance could not be determined.Penumbra coils are visually inspected during in-process inspection and during quality inspection after manufacturing.The product lot number was not provided, therefore, the manufacturing records could not be reviewed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POD
Common Device Name
HCG, KRD
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key15615076
Report Number3005168196-2022-00478
Device Sequence Number5983309
Product Code HCG
UDI-Device Identifier00814548019611
UDI-Public814548019611
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K173614
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 10/31/2022
Report Date (Section F) 01/01/2005
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberRBYPOD6
Device Lot NumberF92274
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report to Manufacturer01/10/2005
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/21/2022
Supplement Date Received by Manufacturer10/21/2022
Initial Report FDA Received Date10/17/2022
Supplement Report FDA Received Date10/31/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/05/2019
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexMale
Date Report Sent to FDA01/01/2005
-
-